RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · IEX Real-Time Price · USD
0.363
-0.010 (-2.73%)
At close: Jul 19, 2024, 4:00 PM
0.380
+0.017 (4.60%)
Pre-market: Jul 22, 2024, 7:29 AM EDT
RedHill Biopharma Market Cap
RedHill Biopharma has a market cap or net worth of $11.58 million as of July 22, 2024. Its market cap has increased by 212.90% in one year.
Market Cap
11.58M
Enterprise Value
6.39M
1-Year Change
212.90%
Ranking
Category
Stock Price
$0.36
Market Cap Chart
Since January 7, 2013, RedHill Biopharma's market cap has decreased from $58.80M to $11.58M, a decrease of -80.31%. That is a compound annual growth rate of -13.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 11.60M | 146.81% |
| Dec 29, 2023 | 4.70M | -47.78% |
| Dec 30, 2022 | 9.00M | -92.54% |
| Dec 31, 2021 | 120.70M | -57.65% |
| Dec 31, 2020 | 285.00M | 65.51% |
| Dec 31, 2019 | 172.20M | 45.81% |
| Dec 31, 2018 | 118.10M | 34.66% |
| Dec 29, 2017 | 87.70M | -34.06% |
| Dec 30, 2016 | 133.00M | 17.49% |
| Dec 31, 2015 | 113.20M | 31.93% |
| Dec 31, 2014 | 85.80M | 37.28% |
| Dec 31, 2013 | 62.50M | 6.29% |
| Jan 7, 2013 | 58.80M | - |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Check-Cap | 11.88M |
| Monopar Therapeutics | 11.86M |
| Lumos Pharma | 11.85M |
| Imunon | 11.75M |
| Eterna Therapeutics | 11.63M |
| Cardio Diagnostics Holdings | 11.57M |
| Calidi Biotherapeutics | 11.30M |
| Vaccinex | 11.25M |